Light Chain Bioscience successfully completes Factor VIII mimetic bispecific antibody discovery for Takeda GENEVA, Switzerland, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Light Chain Bioscience, a company developing bispecific antibodies with a pipeline focused in immuno-oncology, announced that it has achieved a...